Company: PIII
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001140361-25-016302
Chunk: 38

Company: P3 Health Partners Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 38
---
 and cybersecurity risks; |

| • | meeting independently with our internal auditing staff, if any, independent registered public accounting firm and management; |

| • | reviewing and overseeing any related person transactions; and |

| • | preparing the audit committee report required by SEC rules. |

The Audit Committee charter is available on our website at ir.p3hp.org. The members of the Audit Committee are Jeffrey G. Park, Thomas E. Price, M.D. and Greg Wasson. Jeffrey G. Park serves as the Chair of the committee. Our Board has affirmatively determined that each of Jeffrey G. Park, Thomas E. Price, M.D. and Greg Wasson is independent for purposes of serving on an audit committee under Rule 10A-3 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Nasdaq Rules, including those related to Audit Committee membership. The members of our Audit Committee meet the requirements for financial literacy under the applicable Nasdaq rules. In addition, our Board has determined that Jeffrey G. Park qualifies as an “audit committee financial expert,” as such term is defined in Item 407(d)(5) of Regulation S-K, and under the similar Nasdaq Rules requirement that the Audit Committee have a financially sophisticated member. The Audit Committee met six times during the fiscal year ended December 31, 2024.

23

TABLE OF CONTENTS

Compensation and Nominating Committee Our Compensation and Nominating Committee oversees the compensation of our executive officers and recommends to the Board the persons to be nominated or elected as directors of the Company. Our Compensation and Nominating Committee’s responsibilities include, among other things:

| • | reviewing and approving, or recommending for approval to the Board, the compensation of our Chief Executive Officer and our other executive officers; |

| • | overseeing and administering our cash and equity incentive plans; |

| • | reviewing and making recommendations to our Board with respect to director compensation; |

| • | reviewing and discussing annually with management our “Compensation Discussion and Analysis,” to the extent required; |

| • | preparing the annual compensation committee report required by SEC rules, to the extent required; |

| • | administering the Company’s Clawback Policy; |

| • | identifying individuals qualified to become Board members; |

| • | recommending to our Board the persons to be nominated for election as directors and appointed to each Board committee; |

| • | working with the Chief Executive Officer to evaluate our succession plans for the Chief Executive Officer